PROVECTUS BIOPHARMACEUTICALS, INC. Current Assets
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Current Assets of $1.37 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $1.37M.
- 2026-03-31: Assets, Current $460.38K.
- 2025-12-31: Assets, Current $567.87K.
- 2025-09-30: Assets, Current $277.99K.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $1.37M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $460.38K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $567.87K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $277.99K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $568.32K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $649.47K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $976.77K 10-K · filed 2026-03-26 |
| 2024-09-30 | $760.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $800.24K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.01M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.36M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.59M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.58M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.90M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.90M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.28M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.71M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.44M 10-K · filed 2023-03-30 |
| 2021-09-30 | $506.55K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $347.22K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $629.12K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $423.68K 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.16M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.63M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $528.34K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $996.01K 10-K · filed 2021-03-02 |
| 2019-09-30 | $893.98K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.86M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.72M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $1.02M 10-K · filed 2020-03-05 |
| 2018-09-30 | $441.70K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.38M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $744.76K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $958.30K 10-K · filed 2019-03-07 |
| 2017-09-30 | $533.70K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.47M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $887.47K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.83M 10-K · filed 2018-03-23 |
| 2016-09-30 | $5.42M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $5.41M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $10.45M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $14.72M 10-K · filed 2017-03-31 |
| 2015-09-30 | $19.95M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $24.50M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $15.86M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $19.10M 10-K · filed 2016-03-30 |
| 2014-09-30 | $17.77M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $18.13M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $16.65M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $15.70M 10-K · filed 2015-03-12 |
| 2013-09-30 | $8.30M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $4.73M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $4.46M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.22M 10-Q · filed 2013-11-12 |
| 2012-09-30 | $1.86M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $4.14M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $4.95M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $7.71M 10-Q · filed 2012-11-08 |
| 2011-09-30 | $10.85M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $14.48M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $8.09M 10-K · filed 2012-03-14 |